Clinical Trial on Type 2 Diabetes Patients with Kidney Disease

The chapter explores a trial involving patients with obesity and type 2 diabetes who had high-risk chronic kidney disease. It discusses the criteria for patient inclusion, the significance of monitoring urine protein levels, and the necessity for medications like ACE inhibitors or ARBs. The chapter delves into the characteristics of patients in the global trial and emphasizes the importance of SGLT2 inhibitors in managing heart and kidney issues in high-risk individuals.